Generic Pharmaceutical News Today

New Delhi [India], April 19 (ANI/SRV): Medec Dragon Pvt Ltd, India's fastest-growing research-driven Pharmaceutical API Contract Manufacturing Company with over 25+ advanced intermediates being marketed in more than 70 plus countries having WHO-GMP Certified Manufacturing Facilities in building bonds with Local and Global Customers was awarded the most prestigious & coveted "Most Promising Company in Corporate Governance 2023" at the ASSOCHAM's national seminar organized ...

Dr Reddy's Laboratories Ltd on Tuesday said it is among several generic pharmaceutical companies, including Celgene and Bristol Myers Squibb, against which an antitrust litigation has been filed in the US.

Actavis Group and Japan’s ASKA Pharmaceutical have formally signed an agreement establishing a joint company: Actavis ASKA K.K. with its head office in Tokyo. The preliminary agreement was signed last November.

Endo International plc (NASDAQ:NASDAQ:ENDP) Q1 2022 Earnings Conference Call May 6, 2022 07:30 ET Company Participants Laure Park - Senior Vice President, Investor Relations and Corporate...

CHINO HILLS, CA / ACCESSWIRE / June 3, 2021 / SOHM, Inc. (the "Company") (OTC PINK:SHMN), generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today that the Company has received a semi-annual, bi-monthly order for prescription skincare topical products, estimated to have a top-line revenue value of approximately $500k.

Sun Pharmaceutical Industries rose 1.30% to Rs 699.85 after Life Insurance Corporation of India (LIC) purchased 4.83 crore equity shares or 2.016% stake of the drug major. Post transaction, LICs stake in Sun Pharma has increased to 7.026% from 5.010% held earlier. The deal was executed as a market purchase between 23 June 2017 to 17 May 2021. On a consolidated basis, the drug major reported an 87.4% jump in net profit to Rs 1,918.11 crore on 9.2% rise in net sales to Rs 8,781.84 crore in Q3 FY...

Operator Good day, and thank you for standing by. Welcome to the Endo International plc First Quarter 2021 Earnings Conference Call. [Operator Instructions] Please be advised, todays conference is being recorded. [Operator Instructions] I would now like to hand the conference over to speaker today, Laure Park, Senior Vice President of Investor Relations and Corporate Affairs. Please go ahead. Laure Park -- Senior Vice President of Investor Relations and Corporate Affairs Thank you. Good mornin...

The drug major said that one of its wholly-owned subsidiaries has agreed to acquire 428,571 ordinary shares (equivalent to 12.5% stake) in WRS Bioproducts, Australia. WRS Bioproducts is an early stage company based in Australia, developing novel technologies to produce and commercialize supplements and nutraceutical ingredients from diverse algae species. The cost of the said acquisition is 2 million Australian dollars and the company expects to complete the same by 15 March 2021. Sun Pharma ...

Operator Good morning, ladies and gentlemen, and welcome to the Fourth Quarter 2020 Endo International plc Earnings Conference Call.[Operator Instructions] I would now like to turn the conference over to your host, Ms. Laure Park, Vice President, Investor Relations and Corp Affairs. Please go ahead. Laure Park -- Senior Vice President, Investor Relations and Corporate Affairs Good morning and thank you for joining us to discuss our fourth quarter and full year 2020 financial results. Joining m...

Share this article Ray Shelley of Apotex Elected Vice-Chair TORONTO, Feb. 22, 2021 /CNW/ - The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the unanimous election of Mr. Jean-Guy Goulet, Chief Operating Officer of Pharmascience, as Chair of CGPA. Mr. Ray Shelley, Senior Vice President, Commercial Operations – Canada and Caribbean at Apotex Inc., has been unanimously elected as Vice-Chair of CGPA. Mr. Goulet said that, given the lessons learned through maintaining...